AstraZeneca Loses Bid To Nix $42M Award In UK Generic Row
A U.K. appeals court on Thursday upheld a $42 million judgment against AstraZeneca AB for keeping two drugmakers from producing a generic version of its ulcer drug Nexium, ruling the award...To view the full article, register now.
Already a subscriber? Click here to view full article